In just one year, around 115,000 cancer patients in England are diagnosed too late to give them the best chance of survival, according to new calculations* from Cancer Research UK.
This means that nearly half of all cancers diagnosed with a known stage in England are diagnosed at stage 3 or 4. And of these, around 67,000 people are diagnosed at stage 4 – the most advanced stage, leaving them with fewer treatment options and less chance of surviving their disease.
There are lots of things that can influence how early or late someone is diagnosed, but workforce shortages are a large contributor. There is a desperate shortage of NHS medical staff trained to carry out tests that diagnose cancer, meaning that efforts by the health system to diagnose and treat cancer more swiftly are being thwarted.
Last year, the Government made an important pledge to improve the number of people diagnosed with early stage cancer – a jump from two in four diagnosed early to three in four by 2028 which could save thousands of lives. Cancer Research UK has calculated that to reach this target, an extra 100,000 patients must be diagnosed early each year by 2028.**
“We can feel the bottleneck tightening in the NHS – the pressure is mounting on diagnostic staff. We don’t have nearly enough radiologists in the UK right now and far too many patients are waiting too long for scans and results.” Dr Giles Maskell, Cancer Research UK’s radiology expert
NHS staff are working tirelessly to offer the best care possible, and the NHS is implementing important new initiatives to address late diagnosis and improve staff efficiency. But there just aren’t enough of the right staff available on the ground now, and there are no plans to significantly increase the numbers needed to transform the health service.
An earlier diagnosis can be the difference between life and death. If bowel cancer is diagnosed at the earliest stage, more than nine in 10 people will survive, but if it is diagnosed at the latest stage, just one in 10 people will survive their disease for at least five years.
Efforts to diagnose more patients at an early stage means more people being referred urgently for tests, a vital shift for prompt diagnosis and treatment. But increasing referrals have left diagnostic staff under great pressure because of vacant posts, a lack of funding to train new doctors and growing lists of patients.
At least one in 10 of these posts is empty, so the Government needs to urgently invest in the cancer workforce if they plan to save more lives now, and in the future. Without the staff, the Government will not achieve its own ambition.
Emma Greenwood, Cancer Research UK’s director of policy, said: “It’s unacceptable that so many people are diagnosed late. Although survival has improved, it’s not happening fast enough. More referrals to hospital means we urgently need more staff. The Government’s inaction on staff shortages is crippling the NHS, failing cancer patients and the doctors and nurses who are working tirelessly to diagnose and treat them.
“By 2035, one person every minute will be diagnosed with cancer but there’s no plan to increase the number of NHS staff to cope with demand now or the growing numbers in the future. Saving lives from cancer needs to be top of the agenda for the new Government and it must commit to investing in vital NHS staff now to ensure no one dies from cancer unnecessarily.”***
An underpowered workforce is not the sole reason for late diagnoses. Other factors include symptoms being hard to spot, GPs having too little time to investigate people thoroughly, low uptake of screening programmes or the cancer being advanced when detected.
But right now, staff shortages are affecting every part of the pathway. According to work commissioned by Cancer Research UK, it is estimated that by 2027, the NHS needs:****
- An additional 1,700 radiologists – people who report on imaging scans – increasing the total number to nearly 4,800
- To nearly triple its number of oncologists – doctors specialising in treating patients with cancer – a jump from 1,155 to 3,000
- Nearly 2,000 additional therapeutic radiographers – people who give radiotherapy to cancer patients – increasing the total to almost 4,800
By 2035, more than 500,000 people will be diagnosed with cancer in the UK, compared with nearly 360,000 today. With an ageing population, more tests will need to be carried out to diagnose more cancers and diagnose them earlier.
Dr Giles Maskell, Cancer Research UK’s radiology expert, said: “We can feel the bottleneck tightening in the NHS – the pressure is mounting on diagnostic staff. We don’t have nearly enough radiologists in the UK right now and far too many patients are waiting too long for scans and results.
“NHS staff are working as hard as they can, but we won’t be able to care for the rising number of cancer patients unless the resources are found to train more specialist staff. Extra scanners are welcome, but they will achieve nothing without staff to run them and experts to interpret the scans. It’s like buying a fleet of planes with no pilots to fly them.”
Supporting notes provided by Cancer Research UK
* This is the number of patients with a recorded stage, who were diagnosed with cancer at a late stage (stage III and IV) in 2017. The actual number of patients could be greater than this because a record of stage at diagnosis is missing for around 19% of patients. Data source: Stage Breakdown by CCG 2017, Public Health England, http://www.ncin.org.uk/publications/survival_by_stage
**The NHS Long Term Plan states England’s ambition of three quarters of patients to be diagnosed at stage I and II by 2028. With cancer incidence increasing (data based on incidence projections for 2028 in England from Smittenaar et al. 2016), it is estimated that there will be more than 320,000 cancers diagnosed with a recorded stage (assuming data completeness remains the same), of which 240,000 cancer patients need to be diagnosed at stage I or II in order to reach the NHS ambition. That means that by 2028, more than 100,000 additional cancer patients will need to be diagnosed at stage I or II per year.
***The Government has committed to investing £20.5 billion in the NHS over five years, but this does not include investment to train and hire new staff. Funds to address workforce shortages were expected in the Spending Review – due take place in Autumn 2019 but likely to be delayed – however the Treasury has confirmed that any funds announced will cover one year instead of three. The Spending Review will not provide the funds vitally needed for long term workforce planning.
NHS England and Improvement has published an interim workforce plan. But it fails to set out any detail of how we address the long-term staffing crisis in the NHS. We urgently need to see a long-term commitment from the government to increase investment to train and hire more staff.
**** Up to now, workforce planning has been determined by what the NHS can afford, rather than what the NHS will need. In 2018, Cancer Research UK commissioned estimates for the number of staff that will be needed by 2027 in certain key cancer professions to meet the expected increase in cancer diagnoses that year. The report provides estimates for the number of staff needed in 2027 based on 2016 staff numbers. The estimates have been revised based on 2018 staff numbers. https://www.cancerresearchuk.org/sites/default/files/securing_a_cancer_workforce_for_the_best_outcomes_november_2018_full_report.pdf
|Cancer staff||Staff numbers 2018||Estimated staff needed by 2027||Difference|
How were these estimates reached by Cancer Research UK
- The research team interviewed clinicians to understand how much time they spent on various tasks, including time spent with patients
- They multiplied the estimated average time a clinician spent with a patient, by the projected number of cancer cases for 2027
- These estimates do not take into account the likely impact of early diagnosis and treatment initiatives which will require more staff, or changes to services which might release staff time
This article is based on information provided by Cancer Research UK. You can view the original press release here.